Quarterly Results Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Jun'26
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Net Sales
2,066.43
2,153.17
1,756.82
2,209.79
2,700.78
2,574.25
2,309.34
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
2,066.43
2,153.17
1,756.82
2,209.79
2,700.78
2,574.25
2,309.34
Raw Material Cost
1,628.38
1,609.53
1,153.19
1,655.34
1,960.83
1,881.04
1,504.41
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
76.52
74.99
85.06
85.85
93.24
97.40
112.78
Selling and Distribution Expenses
287.05
357.96
416.05
400.20
496.13
465.16
551.48
Other Expenses
-5.73
-4.52
-5.67
-6.00
-5.74
-6.87
-7.67
Total Expenditure (Excl Depreciation)
1,934.70
1,997.24
1,597.56
2,081.41
2,492.81
2,374.91
2,091.96
Operating Profit (PBDIT) excl Other Income
131.7
155.9
159.3
128.4
208
199.3
217.39999999999998
Other Income
6.20
-1.00
16.12
16.63
8.77
13.98
26.46
Operating Profit (PBDIT)
371.09
379.28
380.76
387.46
421.34
429.03
412.12
Interest
76.52
74.99
85.06
85.85
93.24
97.40
112.78
Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
438.05
543.64
603.64
554.45
739.95
693.22
804.93
Depreciation
252.65
252.65
243.96
243.96
235.88
235.88
224.92
Profit Before Tax
41.92
51.64
51.74
57.66
92.21
95.75
74.42
Tax
16.15
16.90
24.28
23.93
25.22
26.53
18.33
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
28.37
35.47
24.55
35.01
66.01
57.49
24.53
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
28.37
35.47
24.55
35.01
66.01
57.49
24.53
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
13.12
13.90
21.36
14.25
19.66
19.13
44.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
41.50
49.38
45.91
49.25
85.66
76.63
68.53
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
5,518.39
5,549.82
5,514.83
5,505.22
5,467.08
5,447.53
5,389.40
Earnings per share (EPS)
0.02
0.02
0.01
0.02
0.04
0.03
0.01
Diluted Earnings per share
0.02
0.02
0.01
0.02
0.04
0.03
0.01
Operating Profit Margin (Excl OI)
5.43%
5.93%
6.87%
5.74%
6.54%
6.96%
6.96%
Gross Profit Margin
14.25%
14.13%
16.83%
13.65%
12.15%
12.88%
12.96%
PAT Margin
1.37%
1.65%
1.4%
1.58%
2.44%
2.23%
1.06%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Jun 2026 is -4.03% vs 22.56% in Mar 2026
Consolidate Net Profit
QoQ Growth in quarter ended Jun 2026 is -15.99% vs 7.63% in Mar 2026
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Jun 2026 is -4.05% vs 4.31% in Mar 2026
Interest
QoQ Growth in quarter ended Jun 2026 is 2.00% vs -11.87% in Mar 2026
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Jun 2026 has fallen from Mar 2026
Compare Quarterly Results Of North China Pharmaceutical Co., Ltd. With
Figures in Million
Consolidate Quarterly Results
Change(CNY)
Change(%)
Net Sales
2,066.43
0
2,066.43
Other Operating Income
0.00
0.00
0.00
Total Operating income
2,066.43
0
2,066.43
Raw Material Cost
1,628.38
0
1,628.38
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
76.52
0
76.52
Selling and Distribution Expenses
287.05
0
287.05
Other Expenses
-5.73
0.00
-5.73
Total Expenditure (Excl Depreciation)
1,934.70
0
1,934.70
Operating Profit (PBDIT) excl Other Income
131.73
0.00
131.73
Other Income
6.20
0
6.20
Operating Profit (PBDIT)
371.09
0
371.09
Interest
76.52
0
76.52
Exceptional Items
0.00
0
0.00
Gross Profit (PBDT)
438.05
0
438.05
Depreciation
252.65
0
252.65
Profit Before Tax
41.92
0
41.92
Tax
16.15
0
16.15
Provisions and contingencies
0
0
0.00
Profit After Tax
28.37
0
28.37
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
28.37
0
28.37
Share in Profit of Associates
0
0
0.00
Minority Interest
13.12
0
13.12
Other related items
0.00
0.00
0.00
Consolidated Net Profit
41.50
0
41.50
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
5,518.39
0
5,518.39
Earnings per share (EPS)
0.02
0
0.02
Diluted Earnings per share
0.02
0
0.02
Operating Profit Margin (Excl OI)
5.43%
0%
0.00
5.43%
Gross Profit Margin
14.25%
0%
0.00
14.25%
PAT Margin
1.37%
0%
0.00
1.37%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 206.64 Million
in Jun 2026Figures in Million
QoQ Growth in quarter ended Jun 2026 is -4.03% vs 22.56% in Mar 2026
YoY Growth in quarter ended Jun 2026 is -23.49% vs 1.02% in Jun 2025
Quarterly - Consolidate Net Profit
Consolidate Net Profit 4.15 Million
in Jun 2026Figures in Million
QoQ Growth in quarter ended Jun 2026 is -15.99% vs 7.63% in Mar 2026
YoY Growth in quarter ended Jun 2026 is -51.58% vs 32.46% in Jun 2025
Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 36.49 Million
in Jun 2026Figures in Million
QoQ Growth in quarter ended Jun 2026 is -4.05% vs 4.31% in Mar 2026
YoY Growth in quarter ended Jun 2026 is -11.56% vs 7.67% in Jun 2025
Quarterly - Interest
Interest 7.65 Million
in Jun 2026Figures in Million
QoQ Growth in quarter ended Jun 2026 is 2.00% vs -11.87% in Mar 2026
YoY Growth in quarter ended Jun 2026 is -17.92% vs -21.15% in Jun 2025
Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 5.43%
in Jun 2026Figures in %
QoQ Growth in quarter ended Jun 2026 has fallen from Mar 2026
YoY Growth in quarter ended Jun 2026 has fallen from Jun 2025
Footer loading
